Real-world insights into treating metastatic castration-sensitive prostate cancer
A group of urologists from across the Dallas region convened for a recent Urology Times Clinical Forum moderated by Matthew L. Wilner, MD, of Urology Clinics of North Texas to discuss evolving approaches to managing metastatic castration-sensitive prostate cancer (mCSPC).